Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
J Hepatol
; 56(1): 176-83, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-21835141
Full text:
1
Database:
MEDLINE
Main subject:
Transcription Factors
/
Proteins
/
Carcinoma, Hepatocellular
/
Histone Deacetylase Inhibitors
/
Liver Neoplasms
Type of study:
Prognostic_studies
Language:
En
Journal:
J Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2012
Type:
Article
Affiliation country:
United States